6Qu B,Liu C,Guo L,et al.The role of liver transplantation in the treatment of hepatic myelopathy:case report with revie of the literature[J].Transplant Proc,2009,41(5):1987.
9Koo JE,Lim YS,Myung SJ,et al.Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt[J].Korean J Hepatol,2008,14(1):89.
2Weissenborn K, Tietge U J, Bokemeyer M, et al. Liver transplantation improves hepatic myelopathy: evidence by three cases [J]. Gastroenterology, 2003, 124(2): 346-351.
3Roberto T jan D, Bernard H. Improvement of hepatic myelopathy after liver transplantation[J]. N Engl J Med, 1999, 340(2):151-155.
4Counsell C, Warlow C. Failure presumed hepatic myelopathy to improve after liver transpaplantation [J]. J Neurol Neurosurg Psychiatry, 1996, 60(5):590.
5Nardone R, Buratti T, Oliviero A, et al. Corticospinal involvement in patients with a portosystemic shunt due to liver cirrhosis: a mep study[J]. J Neurol, 2006, 253( 1 ):81-85.
6Zieve L,Mendelson DF,Goepfert M.Shunt encephalomyelopathy.II.Occurrence of permanent myelopathy.Ann Intern Med.1960;53:53-63.
7Zeng GQ.Myelopathy caused by digestive system diseases.Beijing:People's Medical Publishing House.1997;466-468.
9Medermott WV.Exclusion of the cotton in the treatment of hepatic encephalopathy.New Eng J Med.1962;267:850.
10Walker JG,Emlyn-Williams A,Rosenoer VM,et al.Treatment of chronic portal-systemic encephalopathy by surgical exclusion of colon.Lancet.1965;2(7418):861.
4Leigh AD, Card WI. Hepato-lenticular degeneration. A case asso- ciated with posterio-lateral column degeneration[J]. J Neuropathol Exp Neurol, 1949,8(3) :338-346.
5Su AP, Cao SS, Le Tian B, et al. Effect of transjugular iutrahe- patic portosystemic shunt on glycometabolism in cirrhosis patients [ J ]. Clin Res Hepatol Gastroenterol, 2012,36 ( 1 ) :53-59.
6Stracciari A, Baldin E, Cretella L, et al. Chronic acquired hepa- tocerebral degeneration: effects of liver transplantation on neuro- logical manifestations[J]. Neurol Sci, 2011,32(3) :411-415.
7Caldwell C, Werdiger N, Jakab S, et al. Use of model for end- stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature[J]. Liver Transpl, 2010,16(7) :818-826.
